You don't seem to have a good grasp of Virax's predicament.
The issue of not whether they raise capital at a good share price (positive trial results) or low share price (poor trial results), the issue is whether they raise capital at a low share price (positive trial results) or go out of business (poor trial results).
- Forums
- ASX - By Stock
- VHL
- commercial development of vaccines
commercial development of vaccines, page-11
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)